Source: International Congress 2015 – A more functional view of chest pathology
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Greetje Vande Velde (Leuven, Belgium), Greetje Vande Velde, Jennifer Poelmans, Ellen De Langhe, Amy Hillen, Jeroen Vanoirbeek, Uwe Himmelreich, Rik Lories. Longitudinal micro-CT of preclinical models of lung disease provides biomarkers of disease and therapy that reveal compensatory changes in lung volume. Eur Respir J 2015; 46: Suppl. 59, 3748

Member's Comments

No comment yet.

Related content which might interest you: Preclinical models and imaging biomarkers of lung injury and disease Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Longitudinal micro-CT-derived biomarkers: the new standard readouts for preclinical evaluation of pulmonary fibrosis and therapy Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 Lung function measurements in mouse models of lung disease: What to expect from FEV0.1? Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Combined assessment of regional lung function and morphology using a contrast enhanced Dual-Energy CT protocol: Prospective value of functional imaging biomarkers in longitudinal analysis of patients with Interstitial Lung Disease Source: Virtual Congress 2020 – What is new in interstitial lung diseases of known origin? Year: 2020 Linking MRI and CT imaging with lung function measurements in cryptococcal mouse lung infection Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Longitudinal imaging characterisation of a model of chronic allergic lung inflammation in mice Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 HRCT in the evaluation of functional decay in IPF Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Use of MRI for functional and structural assessment of interstitial lung disease Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 3he MRI and an animal model of interstitial lung disease Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities Year: 2009 Longitudinal assessment of lung fibrosis by micro CT correlates with histological evaluation in bleomycin-induced mice Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 Does the lung clearance index track with disease progression in early childhood? Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Systematic review: In vivo imaging in animal models relevant to drug-induced Interstitial lung disease (DIILD) Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Longitudinal study about the relationship between sarcopenia and lung function Source: International Congress 2018 – New insights in testing lung and respiratory muscle functions Year: 2018 Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases) Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Longitudinal changes of respiratory impedance-based phenotypes in COPD Source: International Congress 2016 – Functional assessment of the airways Year: 2016 The neurogenic inflammation markers in rat’s brain in experimental smoking Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016 Developing a chronic murine model that better reflects the clinical features of the human asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Promotion of lung cancer progression by COPD-like chronic inflammation in a mouse model Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013